Testosterone China Manufacturer,Buy Tren Acetate Uk,Trenbolone Acetate Generic Supplements

Testosterone China Manufacturer,Buy Tren Acetate Uk,Trenbolone Acetate Generic Supplements

Watsa to hold keys to a BlackBerry deal

TORONTO/NEW YORK BlackBerry Ltd is expected to draw preliminary interest from technology companies, buyout firms and Canadian pension funds, but its fate may ultimately rest in "Buy Cheap Jintropin Online" the Buy Tren Acetate Uk hands of its largest shareholder, Prem Watsa's Fairfax Financial Holdings Ltd . investor Warren Buffett, on their side, because he could join in on a private equity deal or at the very least be the bellwether for broader investment sentiment.

"I would imagine that if Fairfax says they are against a particular deal, that would carry a lot of weight, beyond just the 10% that they control," said Richard Steinberg, who heads Fasken Martineau's securities and mergers acquisitions group in Toronto.

Although it remains too early to tell determined buyers from window shoppers, sources familiar with the situation said some of the world's largest private equity firms, including Bain Capital LLC, KKR Co LP and Carlyle Group LP, Australian Levitra are expected to look at BlackBerry when the company launches a sale process.

Leo De Bever, the chief executive of Alberta Investment Management Corp, said he expected some of the largest Canadian pension funds, including his own, to look at any potential deals for the company.

Watsa "Buy Cheap Jintropin Online" stepped down from the BlackBerry board on Monday, citing a potential conflict of "Buy Cheap Jintropin Online" interest, as the company said it was exploring the sale of itself and other options.

Jefferies analysts have suggested that Fairfax could team up with Canadian pension funds and banks to take BlackBerry private, possibly for $15 per share.

Watsa hasn't said how much he would want for his stake in BlackBerry. But one guidepost would be $17 per share, the average price Fairfax has disclosed it has paid to build its 9.9 percent stake in the Canadian "Jintropin (Gensci Pharmaceutical Co. Ltd.)" company over the last three years. BlackBerry shares closed up 1.4 percent at $10.93 in New York on Tuesday.

Fairfax and BlackBerry declined to comment. Representatives of the other companies and private equity firms either declined to comment or did not respond to requests for comment.

The emergence of Watsa as the central figure in the drama unfolding around BlackBerry underscores how quickly Trenbolone Acetate Generic Supplements the situation has spiraled out of the company's control.

BlackBerry has seen its market value nosedive to around $5.7 billion from more than $80 billion at its peak in 2008, as its latest BlackBerry 10 devices struggle to challenge an onslaught from the iPhone and devices running Google Inc's Android operating system.

Fairfax, which has a market value of about $9 billion, became the company's largest shareholder just last year, topping Mike Lazaridis, BlackBerry's co founder and former co chief executive, who has a 5.7 percent stake. BlackBerry's other former co chief executive Jim Balsillie disclosed in February he had sold his remaining shares in the company.

To be sure, Fairfax is only the largest among a plethora of BlackBerry shareholders, two thirds of which will be asked to approve any deal.

The average cost of Watsa's stake in BlackBerry is also low by historical standards, which means it is not a very high bar to clear for a technology company sitting on a massive pile of cash. BlackBerry shares traded at $148 in 2008. They have traded below $20 only in the last two years.

Any deal for BlackBerry remains far from certain. Private equity and other suitors have circled the company for more than two years and have come up empty so far.

Still, other BlackBerry shareholders may take cues from Watsa's moves.

"I don't think (Watsa) is going to look at the various bidders and make qualitative choices. He's going to be making quantitative choices (based on who pays top dollar)," said Ross Healy, a portfolio Testosterone China Manufacturer manager with MacNicol Associates, whose clients own BlackBerry shares.